Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ADAM9 |
| Upstream (Parents) |
|---|
| (<<) ACTB → ADAM9 |
| (<<) CYR61 → ADAM9 |
| (<<) EZR → ADAM9 |
| (<<) HSP90AB1 → ADAM9 |
| (<<) ITGB1 → ADAM9 |
| (<<) MAPK14 → ADAM9 |
| (<<) MAT2A → ADAM9 |
| (<<) MLX → ADAM9 |
| (<<) MMP14 → ADAM9 |
| (<<) PPIB → ADAM9 |
| (<<) PTPN11 → ADAM9 |
| (<<) PTPN12 → ADAM9 |
| (<<) RAB5A → ADAM9 |
| (<<) RAC1 → ADAM9 |
| (<<) RHOA → ADAM9 |
| (<<) ROCK2 → ADAM9 |
| (<<) RYK → ADAM9 |
| (<<) SMURF1 → ADAM9 |
| (<<) STAT2 → ADAM9 |
| (<<) TPM1 → ADAM9 |
| (<<) YWHAH → ADAM9 |
| (<<) YWHAZ → ADAM9 |
| Downstream (Children) |
|---|
| ADAM9 → ADAM17 (>>) |
| ADAM9 → B3GNT2 (>>) |
| ADAM9 → BZW1 (>>) |
| ADAM9 → CABC1 (>>) |
| ADAM9 → CDKN1A (>>) |
| ADAM9 → DNM3 (>>) |
| ADAM9 → EIF4EBP1 (>>) |
| ADAM9 → EMP1 (>>) |
| ADAM9 → FZD10 (>>) |
| ADAM9 → GNA13 (>>) |
| ADAM9 → GNG4 (>>) |
| ADAM9 → GRB2 (>>) |
| ADAM9 → LPIN1 (>>) |
| ADAM9 → LSM1 (>>) |
| ADAM9 → MAP2K4 (>>) |
| ADAM9 → PLAU (>>) |
| ADAM9 → PLAUR (>>) |
| ADAM9 → PYGL (>>) |
| ADAM9 → RASA1 (>>) |
| ADAM9 → RDX (>>) |
| ADAM9 → RRAS2 (>>) |
| ADAM9 → SH3KBP1 (>>) |
| ADAM9 → SLC29A1 (>>) |
| ADAM9 → SOS2 (>>) |
| ADAM9 → TIMP3 (>>) |
